Patent war takes 30 billion from pharmaceutical companies


The value of pharmaceutical companies with WHO-approved Covid-19 vaccines slipped by billions in just one day, after the US and EU opened the door to the end of patents.

Read the interview with Vítor Palmela Fidalgo, legal coordinator at Inventa International, in Jornal de Negócios.